Quest Diagnostics Beats Q2 Revenue, Raises Forecast
Quest Diagnostics posted Q2 2026 revenue of $3.04 billion, up 10.2% and delivering adjusted EPS of $3.12, beating expectations, and it raised its full-year outlook to roughly $11.95–$12.05 billion in revenue and $11.05–$11.25 per share in adjusted earnings amid strong demand across physician, hospital and consumer channels. The results signal sustained demand and positive momentum for diagnostic testing services, with revenue-per-requisition dynamics and volumes supporting the upgrade to guidance.
Business · 36 sources · Jul 26, 2026Read itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About Quest Diagnostics
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Everything about Quest Diagnostics →- Country
- United States
- Headquarters
- Madison, Secaucus
- Inception
- 1967
- Website
- https://www.questdiagnostics.com/